1. Home
  2. LYTS vs CRMD Comparison

LYTS vs CRMD Comparison

Compare LYTS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYTS
  • CRMD
  • Stock Information
  • Founded
  • LYTS 1976
  • CRMD 2006
  • Country
  • LYTS United States
  • CRMD United States
  • Employees
  • LYTS N/A
  • CRMD N/A
  • Industry
  • LYTS Building Products
  • CRMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • LYTS Consumer Discretionary
  • CRMD Health Care
  • Exchange
  • LYTS Nasdaq
  • CRMD Nasdaq
  • Market Cap
  • LYTS 518.5M
  • CRMD 464.7M
  • IPO Year
  • LYTS N/A
  • CRMD 2010
  • Fundamental
  • Price
  • LYTS $15.92
  • CRMD $11.66
  • Analyst Decision
  • LYTS Strong Buy
  • CRMD Strong Buy
  • Analyst Count
  • LYTS 2
  • CRMD 6
  • Target Price
  • LYTS $26.00
  • CRMD $15.00
  • AVG Volume (30 Days)
  • LYTS 158.8K
  • CRMD 2.2M
  • Earning Date
  • LYTS 04-24-2025
  • CRMD 05-06-2025
  • Dividend Yield
  • LYTS 1.26%
  • CRMD N/A
  • EPS Growth
  • LYTS N/A
  • CRMD N/A
  • EPS
  • LYTS 0.72
  • CRMD 0.28
  • Revenue
  • LYTS $547,316,000.00
  • CRMD $82,553,827.00
  • Revenue This Year
  • LYTS $20.24
  • CRMD $207.65
  • Revenue Next Year
  • LYTS $7.64
  • CRMD $50.13
  • P/E Ratio
  • LYTS $22.11
  • CRMD $42.08
  • Revenue Growth
  • LYTS 17.89
  • CRMD N/A
  • 52 Week Low
  • LYTS $13.63
  • CRMD $3.61
  • 52 Week High
  • LYTS $25.50
  • CRMD $13.85
  • Technical
  • Relative Strength Index (RSI)
  • LYTS 50.15
  • CRMD 71.85
  • Support Level
  • LYTS $15.32
  • CRMD $8.72
  • Resistance Level
  • LYTS $16.25
  • CRMD $9.82
  • Average True Range (ATR)
  • LYTS 0.67
  • CRMD 0.67
  • MACD
  • LYTS 0.17
  • CRMD 0.40
  • Stochastic Oscillator
  • LYTS 80.22
  • CRMD 84.78

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: